Detalles de la búsqueda
1.
Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials.
Value Health
; 26(10): 1543-1548, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37422075
2.
Psychometrics of patient-reported bother from side effects of treatment single-items in industry-sponsored oncology trials.
Qual Life Res
; 32(9): 2601-2615, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37119353
3.
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study.
Br J Haematol
; 193(2): 325-338, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33605445
4.
Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors.
Haemophilia
; 27(2): 221-228, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33506955
5.
Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study.
Haemophilia
; 27(3): 398-407, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33576546
6.
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer.
Cancer
; 126(13): 3132-3139, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32286687
7.
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma.
Ann Hematol
; 99(12): 2837-2846, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314038
8.
Determining meaningful health-related quality-of-life improvement in persons with haemophilia A using the Haemophilia Quality of Life Questionnaire for Adults (Haem-A-QoL).
Haemophilia
; 26(6): 1019-1030, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33084166
9.
Health-related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors-Results from the HAVEN 2 study.
Haemophilia
; 26(6): 1009-1018, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33084175
10.
Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional study.
Pediatr Blood Cancer
; 67(10): e28474, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32776489
11.
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS).
Haemophilia
; 25(3): 382-391, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31016855
12.
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study.
Haemophilia
; 25(1): 33-44, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30427582
13.
Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events: Methods for item selection in industry-sponsored oncology clinical trials.
Clin Trials
; 15(6): 616-623, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30230365
14.
Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone.
Ann Hematol
; 96(2): 253-259, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27900446
15.
Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies.
Haemophilia
; 27(6): e772-e775, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34623725
16.
Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.
J Oncol Pharm Pract
; 22(5): 666-78, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26320127
17.
Are changes in patient-reported outcomes prognostic for diffuse large B-Cell lymphoma survival? Results from the GOYA trial.
J Patient Rep Outcomes
; 8(1): 31, 2024 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38498084
18.
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
Thyroid
; 34(1): 26-40, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38009200
19.
Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers.
Psychooncology
; 22(3): 555-63, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22290823
20.
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.
Lancet Oncol
; 12(3): 256-62, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21306953